{"id":"https://openalex.org/W2184401588","doi":null,"title":"Treatment possibilities of Alzheimer's disease.","display_name":"Treatment possibilities of Alzheimer's disease.","publication_year":2004,"publication_date":"2004-12-01","ids":{"openalex":"https://openalex.org/W2184401588","mag":"2184401588","pmid":"https://pubmed.ncbi.nlm.nih.gov/15825676"},"language":"en","primary_location":{"id":"pmid:15825676","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15825676","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113539152","display_name":"I. Miklya","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I101202996","display_name":"Semmelweis University","ror":"https://ror.org/01g9ty582","country_code":"HU","type":"education","lineage":["https://openalex.org/I101202996"]}],"countries":["HU"],"is_corresponding":false,"raw_author_name":"I Miklya","raw_affiliation_strings":["Semmelweis University, Faculty of General Medicine, Department of Pharmacology and Pharmacotherapy, Budapest, Hungary"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Semmelweis University, Faculty of General Medicine, Department of Pharmacology and Pharmacotherapy, Budapest, Hungary","institution_ids":["https://openalex.org/I101202996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5052139993","display_name":"P\u00e9ter Gaszner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Gaszner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":"4","first_page":"200","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.003800000064074993,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.00279999990016222,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9929999709129333},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9559999704360962},{"id":"https://openalex.org/keywords/selegiline","display_name":"selegiline","score":0.824999988079071},{"id":"https://openalex.org/keywords/bilevel-positive-airway-pressure","display_name":"bilevel positive airway pressure","score":0.9229999780654907},{"id":"https://openalex.org/keywords/neurodegenerative-disease-prevention","display_name":"neurodegenerative disease prevention","score":0.6840000152587891},{"id":"https://openalex.org/keywords/glutamatergic-neurotransmission","display_name":"glutamatergic neurotransmission","score":0.9629999995231628},{"id":"https://openalex.org/keywords/antioxidants","display_name":"antioxidants","score":0.9639999866485596},{"id":"https://openalex.org/keywords/anti-inflammatory-agents","display_name":"anti-inflammatory agents","score":0.9919999837875366},{"id":"https://openalex.org/keywords/clinical-trial-design","display_name":"clinical trial design","score":0.7850000262260437},{"id":"https://openalex.org/keywords/sex-differences-in-alzheimer-s-disease","display_name":"sex differences in Alzheimer's disease","score":0.6589999794960022},{"id":"https://openalex.org/keywords/age-related-neurodegeneration","display_name":"age-related neurodegeneration","score":0.7770000100135803}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.798100471496582},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.664182186126709},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5993250608444214},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5326843857765198},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49259454011917114},{"id":"https://openalex.org/C2780648746","wikidata":"https://www.wikidata.org/wiki/Q28208871","display_name":"Glutamatergic","level":4,"score":0.47181713581085205},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4277113676071167},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.42335930466651917},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.20672962069511414},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000978","descriptor_name":"Antiparkinson Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001572","descriptor_name":"Benzofurans","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005069","descriptor_name":"Evaluation Studies as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008636","descriptor_name":"Mesencephalon","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008636","descriptor_name":"Mesencephalon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012107","descriptor_name":"Research Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012642","descriptor_name":"Selegiline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015203","descriptor_name":"Reproducibility of Results","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020022","descriptor_name":"Genetic Predisposition to Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:15825676","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15825676","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":59,"referenced_works":["https://openalex.org/W17131581","https://openalex.org/W1922689867","https://openalex.org/W1968257988","https://openalex.org/W1969887156","https://openalex.org/W1970921883","https://openalex.org/W1974206638","https://openalex.org/W1975828119","https://openalex.org/W1975975999","https://openalex.org/W1976234821","https://openalex.org/W1976333758","https://openalex.org/W1976923181","https://openalex.org/W1980260502","https://openalex.org/W1982824019","https://openalex.org/W1984770777","https://openalex.org/W1991720146","https://openalex.org/W1991818385","https://openalex.org/W1993021091","https://openalex.org/W1994264749","https://openalex.org/W1997886955","https://openalex.org/W1998501993","https://openalex.org/W1999326187","https://openalex.org/W2002806269","https://openalex.org/W2008079372","https://openalex.org/W2009385596","https://openalex.org/W2013177189","https://openalex.org/W2017273813","https://openalex.org/W2018593447","https://openalex.org/W2018786479","https://openalex.org/W2029603577","https://openalex.org/W2035365016","https://openalex.org/W2043481087","https://openalex.org/W2043509775","https://openalex.org/W2046705186","https://openalex.org/W2047961360","https://openalex.org/W2048532208","https://openalex.org/W2056837063","https://openalex.org/W2059586369","https://openalex.org/W2067201874","https://openalex.org/W2070174066","https://openalex.org/W2070754102","https://openalex.org/W2071032510","https://openalex.org/W2071429055","https://openalex.org/W2080496794","https://openalex.org/W2084553926","https://openalex.org/W2101265858","https://openalex.org/W2102393260","https://openalex.org/W2117396078","https://openalex.org/W2122938359","https://openalex.org/W2127401575","https://openalex.org/W2131098844","https://openalex.org/W2140599738","https://openalex.org/W2158092299","https://openalex.org/W2169152986","https://openalex.org/W2170121669","https://openalex.org/W2267963721","https://openalex.org/W2326200998","https://openalex.org/W2408730194","https://openalex.org/W2413361101","https://openalex.org/W2463514815"],"related_works":["https://openalex.org/W2499864907","https://openalex.org/W6980630720","https://openalex.org/W2060029708","https://openalex.org/W1974498242","https://openalex.org/W2260717297","https://openalex.org/W2092725163","https://openalex.org/W60328733","https://openalex.org/W2412318728","https://openalex.org/W251808897","https://openalex.org/W7097683195"],"abstract_inverted_index":{"A":[0],"brief":[1],"summary":[2],"of":[3,7,15,44,53,59,69,81,118,169,176,206,214,218,224,236],"the":[4,21,31,40,51,57,67,70,79,82,95,116,124,133,173,177,187,197,204,212,216,234],"current":[5],"treatment":[6,18],"Alzheimer":[8],"disease":[9,90],"(AD)":[10],"(cholinergic":[11],"replacement":[12],"therapy,":[13],"influence":[14],"glutamatergic":[16],"neurotransmission,":[17],"based":[19],"on":[20],"beta-amyloid":[22],"cascade":[23],"theory,":[24],"antioxidants,":[25],"anti-inflammatory":[26],"drugs)":[27],"clearly":[28],"proves":[29],"that":[30,56,93,231],"applied":[32],"strategies":[33],"are":[34,100],"practically":[35],"inefficient.":[36],"We":[37,189],"describe":[38],"therefore":[39,191],"rationale":[41],"and":[42,88,107,139,163,227],"design":[43],"a":[45,60,193,225,239],"reasonable":[46],"clinical":[47,125],"trial":[48,126],"to":[49,66,76,122,144],"test":[50],"validity":[52],"Knoll's":[54],"concept":[55],"administration":[58],"synthetic":[61,178],"mesencephalic":[62,179],"enhancer":[63,180],"substance":[64],"prior":[65],"precipitation":[68],"symptoms":[71,217],"is":[72,238],"our":[73],"only":[74],"chance":[75],"significantly":[77,232],"reduce":[78],"prevalence":[80,235],"two":[83],"main":[84],"neurodegenerative":[85,184],"disorders":[86],"AD":[87,145,219,237],"Parkinson's":[89],"(PD).":[91],"Considering":[92],"in":[94,112,115,127,132,151,186,196,203],"population":[96],"over":[97],"65":[98],"there":[99],"substantial":[101],"sex":[102],"(68%":[103],"female,":[104],"32%":[105],"male)":[106],"geographical":[108],"(highest":[109],"rate:":[110],"10%":[111],"USA)":[113],"differences":[114],"incidence":[117],"AD,":[119],"we":[120],"propose":[121],"perform":[123],"75-85":[128],"year":[129],"old":[130],"females":[131],"USA.":[134],"Individuals":[135],"without":[136],"(Group":[137,141],"1)":[138],"with":[140,158,211],"2)":[142],"predisposition":[143],"should":[146,154],"be":[147,155,243],"selected.":[148],"One":[149],"third":[150],"each":[152],"group":[153],"treated":[156,201],"daily":[157],"placebo,":[159],"(-)-deprenyl":[160],"(1":[161,165],"mg)":[162],"(-)-BPAP":[164],"mg),":[166],"respectively.":[167],"Series":[168],"studies":[170],"proved":[171],"already":[172],"protective":[174],"effect":[175],"substances":[181],"against":[182],"age-related":[183],"changes":[185],"brain.":[188],"may":[190],"expect":[192],"significant":[194],"difference":[195],"placebo":[198],"versus":[199],"drug":[200],"groups":[202],"number":[205],"individuals":[207],"who":[208],"will":[209],"precipitate":[210],"passing":[213],"time":[215],"or":[220],"PD.":[221],"The":[222],"introduction":[223],"safe":[226],"efficient":[228],"prophylactic":[229],"therapy":[230],"decreases":[233],"necessity":[240],"which":[241],"cannot":[242],"further":[244],"postponed.":[245]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}